← Back to Search

NuestraSaludSegura Program for COVID-19 Testing and Vaccination

N/A

Recruiting

Led By Scott D Rhodes, PhD

Research Sponsored by Wake Forest University Health Sciences

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

participant must be ≥ 18 years of age

participant must be ≥18 years of age

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline

Awards & highlights

Study Summary

This trial aims to address the social, ethical, and behavioral implications of COVID-19 testing and vaccination within Latinx communities in order to increase uptake of these lifesaving interventions.

Who is the study for?

This trial is for Spanish-speaking individuals who are at least 18 years old and self-identify as Hispanic/Latinx. They must provide informed consent to participate. For certain parts of the study, participants also need to have received a COVID-19 vaccination.Check my eligibility

What is being tested?

The study aims to understand barriers faced by Latinx communities in accessing COVID-19 testing and vaccinations. It will test 'NuestraSaludSegura', which combines peer navigation with mobile health (mHealth) strategies, designed specifically for Spanish speakers.See study design

What are the potential side effects?

Since this trial focuses on increasing access to testing and vaccination rather than administering drugs or medical procedures, it does not directly involve side effects from interventions.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 18 years old or older.

Select...

I am 18 years old or older.

Select...

I speak Spanish.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Doses of vaccine received - Johnson and Johnson

Vaccines

Doses of vaccine received - Pfizer

+4 more

Trial Design

1Treatment groups

Experimental Treatment

Group I: Spanish-speaking Latinx communitiesExperimental Treatment1 Intervention

Individual in-depth interviews with Spanish-speaking Latinx participants

0 / 3Eligibility criteria met

Find a Location

Who is running the clinical trial?

Wake Forest University Health SciencesLead Sponsor

1,242 Previous Clinical Trials

1,004,157 Total Patients Enrolled

Scott D Rhodes, PhDPrincipal InvestigatorWake Forest University Health Sciences

4 Previous Clinical Trials

792 Total Patients Enrolled

Media Library

Vaccinations Research Study Groups: Spanish-speaking Latinx communities

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is it still feasible to join this clinical experiment?

"The entry for this trial on clinicaltrials.gov attests that it is not currently recruiting patients, with the first post having been made in December 1st 2022 and the last update occurring July 22nd 2022. However, there are still 1041 other studies actively searching for participants."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

COVID-19 Testing and Vaccination Among Spanish Speakers

2023. "COVID-19 Testing and Vaccination Among Spanish Speakers". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05302908.

All > Covid 19 > Coronavirus